• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis by real-time PCR of five transport and conservation mediums of nasopharyngeal swab samples to COVID-19 diagnosis in Santiago of Chile.实时荧光 PCR 分析智利圣地亚哥鼻咽拭子样本 5 种运输和保存介质用于 COVID-19 诊断。
J Med Virol. 2022 Mar;94(3):1167-1174. doi: 10.1002/jmv.27446. Epub 2021 Nov 15.
2
Evaluation and comparison of the sensitivity of three commercial RT-qPCR kits used for the detection of SARS-CoV-2 in Santiago, Chile.评价和比较三种用于检测智利圣地亚哥 SARS-CoV-2 的商业 RT-qPCR 试剂盒的灵敏度。
Front Public Health. 2022 Nov 28;10:1010336. doi: 10.3389/fpubh.2022.1010336. eCollection 2022.
3
Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Is Comparable in Clinical Samples Preserved in Saline or Viral Transport Medium.在盐水中或病毒运输介质中保存的临床样本中,严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的检测结果相当。
J Mol Diagn. 2020 Jul;22(7):871-875. doi: 10.1016/j.jmoldx.2020.04.209. Epub 2020 May 13.
4
Dacron swab and PBS are acceptable alternatives to flocked swab and viral transport media for SARS-CoV-2.对于 SARS-CoV-2,使用涤纶拭子和磷酸盐缓冲液(PBS)可以替代植绒拭子和病毒运输介质。
Diagn Microbiol Infect Dis. 2021 Jan;99(1):115209. doi: 10.1016/j.diagmicrobio.2020.115209. Epub 2020 Sep 16.
5
Sensitivity analysis of rapid antigen tests for the Omicron SARS-CoV-2 variant detection from nasopharyngeal swab samples collected in Santiago of Chile.来自智利圣地亚哥采集的鼻咽拭子样本中奥密克戎 SARS-CoV-2 变异株快速抗原检测的敏感性分析。
Front Public Health. 2022 Oct 20;10:976875. doi: 10.3389/fpubh.2022.976875. eCollection 2022.
6
A Cold Chain-Independent Specimen Collection and Transport Medium Improves Diagnostic Sensitivity and Minimizes Biosafety Challenges of COVID-19 Molecular Diagnosis.一种无需冷链的标本采集和运输介质可提高 COVID-19 分子诊断的诊断灵敏度并降低生物安全挑战。
Microbiol Spectr. 2021 Dec 22;9(3):e0110821. doi: 10.1128/Spectrum.01108-21. Epub 2021 Dec 8.
7
Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR.验证盐水、PBS 和一种本地生产的 VTM 在不同储存条件下通过 qRT-PCR 检测 SARS-CoV-2 病毒的效果。
PLoS One. 2023 Feb 13;18(2):e0280685. doi: 10.1371/journal.pone.0280685. eCollection 2023.
8
Temporal stability and detection sensitivity of the dry swab-based diagnosis of SARS-CoV-2.基于干式拭子的 SARS-CoV-2 诊断的时间稳定性和检测灵敏度。
J Biosci. 2021;46(4). doi: 10.1007/s12038-021-00216-9.
9
Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.临床环境中,自我采集唾液与鼻咽拭子用于 SARS-CoV-2 分子检测的诊断性能比较。
Microbiol Spectr. 2021 Dec 22;9(3):e0046821. doi: 10.1128/Spectrum.00468-21. Epub 2021 Nov 3.
10
Evaluation of the impact of pre-analytical conditions on sample stability for the detection of SARS-CoV-2 RNA.评估分析前条件对 SARS-CoV-2 RNA 检测样本稳定性的影响。
J Virol Methods. 2022 Nov;309:114607. doi: 10.1016/j.jviromet.2022.114607. Epub 2022 Aug 13.

引用本文的文献

1
Assessment of DNA/RNA Defend Pro: An Inactivating Sample Collection Buffer for Enhanced Stability, Extraction-Free PCR, and Rapid Antigen Testing of Nasopharyngeal Swab Samples.评估 DNA/RNA 防御 Pro:一种用于增强稳定性、无需提取的 PCR 以及鼻咽拭子样品快速抗原检测的灭活样本采集缓冲液。
Int J Mol Sci. 2024 Aug 22;25(16):9097. doi: 10.3390/ijms25169097.
2
A retrospective study suggests 55 days of persistence of SARS-CoV-2 during the first wave of the pandemic in Santiago de Chile.一项回顾性研究表明,在智利圣地亚哥第一波疫情期间,新冠病毒(SARS-CoV-2)持续存在了55天。
Heliyon. 2024 Jan 18;10(7):e24419. doi: 10.1016/j.heliyon.2024.e24419. eCollection 2024 Apr 15.
3
Simian immunodeficiency virus and storage buffer: Field-friendly preservation methods for RNA viral detection in primate feces.猴免疫缺陷病毒和储存缓冲液:用于灵长类动物粪便中 RNA 病毒检测的现场友好型保存方法。
mSphere. 2023 Dec 20;8(6):e0048423. doi: 10.1128/msphere.00484-23. Epub 2023 Nov 30.
4
An ecological study on reinfection rates using a large dataset of RT-qPCR tests for SARS-CoV-2 in Santiago of Chile.智利圣地亚哥基于大量 RT-qPCR 检测 SARS-CoV-2 的数据集进行再感染率的生态学研究。
Front Public Health. 2023 Jul 10;11:1191377. doi: 10.3389/fpubh.2023.1191377. eCollection 2023.
5
Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR.验证盐水、PBS 和一种本地生产的 VTM 在不同储存条件下通过 qRT-PCR 检测 SARS-CoV-2 病毒的效果。
PLoS One. 2023 Feb 13;18(2):e0280685. doi: 10.1371/journal.pone.0280685. eCollection 2023.
6
Genomic Evidence Suggests Viral Persistence of SARS-CoV-2 for 386 Days in Health Worker: A Case Report from Santiago of Chile.基因组证据表明新冠病毒在一名医护人员体内持续存在386天:来自智利圣地亚哥的病例报告
Infect Dis Rep. 2022 Nov 30;14(6):971-978. doi: 10.3390/idr14060096.
7
Evaluation and comparison of the sensitivity of three commercial RT-qPCR kits used for the detection of SARS-CoV-2 in Santiago, Chile.评价和比较三种用于检测智利圣地亚哥 SARS-CoV-2 的商业 RT-qPCR 试剂盒的灵敏度。
Front Public Health. 2022 Nov 28;10:1010336. doi: 10.3389/fpubh.2022.1010336. eCollection 2022.
8
First Identification of Reinfection by a Genetically Different Variant of SARS-CoV-2 in a Homeless Person from the Metropolitan Area of Santiago, Chile.首例由智利圣地亚哥大都市地区一名无家可归者体内携带的遗传上不同变异株引起的 SARS-CoV-2 再感染的鉴定。
J Environ Public Health. 2022 Apr 27;2022:3859071. doi: 10.1155/2022/3859071. eCollection 2022.
9
Description of Symptoms Caused by the Infection of the SARS-CoV-2 B.1.621 (Mu) Variant in Patients With Complete CoronaVac Vaccination Scheme: First Case Report From Santiago of Chile.完全接种科兴疫苗的患者感染 SARS-CoV-2 B.1.621(Mu)变异株后症状描述:来自智利圣地亚哥的首例报告。
Front Public Health. 2022 Mar 21;10:797569. doi: 10.3389/fpubh.2022.797569. eCollection 2022.

本文引用的文献

1
Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples.使用唾液样本进行 SARS-CoV-2 监测的机器人 RNA 提取。
PLoS One. 2021 Aug 5;16(8):e0255690. doi: 10.1371/journal.pone.0255690. eCollection 2021.
2
Inactivation of SARS-CoV-2 virus in saliva using a guanidium based transport medium suitable for RT-PCR diagnostic assays.使用适用于逆转录聚合酶链反应(RT-PCR)诊断检测的基于胍盐的转运培养基使唾液中的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒失活。
PLoS One. 2021 Jun 11;16(6):e0252687. doi: 10.1371/journal.pone.0252687. eCollection 2021.
3
A method for detection of SARS-CoV-2 RNA in healthy human stool: a validation study.健康人体粪便中 SARS-CoV-2 RNA 的检测方法:一项验证研究。
Lancet Microbe. 2021 Jun;2(6):e259-e266. doi: 10.1016/S2666-5247(21)00059-8. Epub 2021 Mar 31.
4
The use of denaturing solution as collection and transport media to improve SARS-CoV-2 RNA detection and reduce infection of laboratory personnel.使用变性溶液作为采集和运输介质,以提高 SARS-CoV-2 RNA 的检测率并降低实验室人员感染的风险。
Braz J Microbiol. 2021 Jun;52(2):531-539. doi: 10.1007/s42770-021-00469-4. Epub 2021 Mar 31.
5
Optimal preparation of SARS-CoV-2 viral transport medium for culture.用于培养的新型冠状病毒2型病毒运输培养基的优化制备
Virol J. 2021 Mar 10;18(1):53. doi: 10.1186/s12985-021-01525-z.
6
Criticality of In-House Preparation of Viral Transport Medium in Times of Shortage During COVID-19 Pandemic.新冠疫情期间短缺时期病毒运输培养基内部制备的关键性
Lab Med. 2021 Mar 15;52(2):e39-e45. doi: 10.1093/labmed/lmaa099.
7
Evaluation of transport media for laboratory detection of SARS-CoV-2 in upper respiratory tract swab specimens.用于实验室检测上呼吸道拭子标本中 SARS-CoV-2 的运输介质评估。
J Med Virol. 2021 May;93(5):2774-2781. doi: 10.1002/jmv.26643. Epub 2021 Mar 1.
8
Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing.评估市售用于 SARS-CoV-2 灭活的病毒运输介质 (VTM) 及其在即时检测 (POC) 中的应用。
Viruses. 2020 Oct 23;12(11):1208. doi: 10.3390/v12111208.
9
Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent.实验室生物安全措施涉及 SARS-CoV-2 和被归类为 3 级风险的生物制剂。
Pathology. 2020 Dec;52(7):790-795. doi: 10.1016/j.pathol.2020.09.006. Epub 2020 Sep 30.
10
Diagnosis of SARS-CoV-2 by RT-PCR Using Different Sample Sources: Review of the Literature.采用不同样本来源的 RT-PCR 检测 SARS-CoV-2:文献综述。
Ear Nose Throat J. 2021 Apr;100(2_suppl):131S-138S. doi: 10.1177/0145561320953231. Epub 2020 Aug 31.

实时荧光 PCR 分析智利圣地亚哥鼻咽拭子样本 5 种运输和保存介质用于 COVID-19 诊断。

Analysis by real-time PCR of five transport and conservation mediums of nasopharyngeal swab samples to COVID-19 diagnosis in Santiago of Chile.

机构信息

Centro de Biotecnología Acuícola, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile.

Centro de Nanociencia y Nanotecnología CEDENNA, Universidad de Santiago de Chile, Santiago, Chile.

出版信息

J Med Virol. 2022 Mar;94(3):1167-1174. doi: 10.1002/jmv.27446. Epub 2021 Nov 15.

DOI:10.1002/jmv.27446
PMID:34755352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8662110/
Abstract

Due to the COVID-19 pandemic, many transport kits have been manufactured to preserve and transport nasopharyngeal swab samples (NPSs) from patients. However, there is no information on the performance of the different virus transport media (VTM) used in COVID-19 diagnosis in the population of Santiago de Chile. We compared the RT-qPCR amplification profile of five different viral transport kit mediums, including DNA/RNA Shield™, NAT, VTM-N, Ezmedlab™, and phosphate-buffered saline (PBS), for NPSs from Central Metropolitan Health Service, Santiago, Chile. The DNA/RNA Shield™ medium showed a better performance in terms of Cq and RFU values for the internal reference RNase P and viral ORF1ab probes. By contrast, the PBS transport medium registered higher Cq values for the viral and reference gene, compared to the other VTM. DNA/RNA Shield™ shows higher relative fluorescence units (RFUs) and lower Cq values for the reference gene. Collectively, our results suggest that the PBS medium could compromise the sample diagnosis because of its lower RT-qPCR performance. The NAT, Ezmedlab and VTM-N, and DNA/RNA Shield™ media show acceptable RT-qPCR parameters and, consequently, seem suitable for use in COVID-19 diagnosis.

摘要

由于 COVID-19 大流行,已经制造了许多运输工具包,以保存和运输来自患者的鼻咽拭子样本 (NPS)。然而,在智利圣地亚哥的人群中,关于用于 COVID-19 诊断的不同病毒运输介质 (VTM) 的性能尚无信息。我们比较了来自智利圣地亚哥中央大都市卫生局的 NPS 中五种不同病毒运输试剂盒介质的 RT-qPCR 扩增图谱,包括 DNA/RNA Shield™、NAT、VTM-N、Ezmedlab™ 和磷酸盐缓冲盐水 (PBS)。DNA/RNA Shield™ 介质在内部参考 RNase P 和病毒 ORF1ab 探针的 Cq 和 RFU 值方面表现出更好的性能。相比之下,与其他 VTM 相比,PBS 运输介质的病毒和参考基因的 Cq 值更高。DNA/RNA Shield™ 显示出更高的相对荧光单位 (RFU) 和参考基因的更低 Cq 值。总的来说,我们的结果表明 PBS 介质可能会因 RT-qPCR 性能较低而影响样本诊断。NAT、Ezmedlab 和 VTM-N 以及 DNA/RNA Shield™ 介质显示出可接受的 RT-qPCR 参数,因此似乎适合用于 COVID-19 诊断。